| 000 | 01085 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250517211045.0 | ||
| 008 | ####s 0 0 eng d | ||
| 022 | _a1178-6973 | ||
| 024 | 7 |
_a10.2147/IDR.S160593 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAhmed, Ossama A | |
| 245 | 0 | 0 |
_aOutcomes and predictors of treatment response with sofosbuvir plus daclatasvir with or without ribavirin in Egyptian patients with genotype 4 hepatitis C virus infection. _h[electronic resource] |
| 260 |
_bInfection and drug resistance _c2018 |
||
| 300 |
_a441-445 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 700 | 1 | _aElsebaey, Mohamed A | |
| 700 | 1 | _aFouad, Mohamed Hassan A | |
| 700 | 1 | _aElashry, Heba | |
| 700 | 1 | _aElshafie, Ahmed I | |
| 700 | 1 | _aElhadidy, Ahmed A | |
| 700 | 1 | _aEsheba, Noha E | |
| 700 | 1 | _aElnaggar, Mohammed H | |
| 700 | 1 | _aSoliman, Shaimaa | |
| 700 | 1 | _aAbd-Elsalam, Sherief | |
| 773 | 0 |
_tInfection and drug resistance _gvol. 11 _gp. 441-445 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2147/IDR.S160593 _zAvailable from publisher's website |
| 999 |
_c28261379 _d28261379 |
||